
The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …

Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …

Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …

AstraZeneca (LSE: AZN) has entered into a licencing agreement with Ironwood Pharmaceuticals (NASDAQ: IRWD) which will see the latter granted …

Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …

AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …

